SMLR Stock Overview
Semler Scientific, Inc. provides technology solutions to improve the clinical effectiveness and efficiency of healthcare providers in the United States.
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 3/6 |
| Past Performance | 3/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
My Notes
NewNotes are coming soon
Semler Scientific, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$24.50 |
| 52 Week High | US$81.99 |
| 52 Week Low | US$23.25 |
| Beta | 0.69 |
| 1 Month Change | -26.87% |
| 3 Month Change | -22.71% |
| 1 Year Change | -69.79% |
| 3 Year Change | -52.23% |
| 5 Year Change | 240.28% |
| Change since IPO | 250.50% |
Recent News & Updates
Recent updates
Calculating The Intrinsic Value Of Semler Scientific, Inc. (NASDAQ:SMLR)
Dec 14
Semler Scientific: Growth, Profits, And Valuation Models Support A Buy
Aug 02Semler Scientific: A Small Company Solving A Big Problem
Apr 21Things Look Grim For Semler Scientific, Inc. (NASDAQ:SMLR) After Today's Downgrade
Mar 08Semler Scientific: Why I'm Buying
Mar 05Should You Investigate Semler Scientific, Inc. (NASDAQ:SMLR) At US$52.64?
Mar 02Semler's Unique Business Model Is Fueling Profitable Growth
Feb 23Better Price For Semler Is Likely
Jan 05Semler Scientific's (NASDAQ:SMLR) Earnings Are Weaker Than They Seem
Nov 12It Looks Like The CEO Of Semler Scientific, Inc. (NASDAQ:SMLR) May Be Underpaid Compared To Peers
Oct 15Semler Scientific: Rapidly Growing Medical Device Company
Oct 14There's Reason For Concern Over Semler Scientific, Inc.'s (NASDAQ:SMLR) Massive 28% Price Jump
Oct 14Shareholder Returns
| SMLR | US Medical Equipment | US Market | |
|---|---|---|---|
| 7D | -37.5% | 2.0% | 0.9% |
| 1Y | -69.8% | -11.7% | -10.9% |
Return vs Industry: SMLR underperformed the US Medical Equipment industry which returned -11.7% over the past year.
Return vs Market: SMLR underperformed the US Market which returned -10.9% over the past year.
Price Volatility
| SMLR volatility | |
|---|---|
| SMLR Average Weekly Movement | 13.7% |
| Medical Equipment Industry Average Movement | 8.5% |
| Market Average Movement | 6.7% |
| 10% most volatile stocks in US Market | 17.5% |
| 10% least volatile stocks in US Market | 2.8% |
Stable Share Price: SMLR is more volatile than 75% of US stocks over the past 3 months, typically moving +/- 14% a week.
Volatility Over Time: SMLR's weekly volatility (14%) has been stable over the past year, but is still higher than 75% of US stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2007 | 124 | Doug Murphy-Chutorian | https://www.semlerscientific.com |
Semler Scientific, Inc. provides technology solutions to improve the clinical effectiveness and efficiency of healthcare providers in the United States. The company’s products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient’s vascular condition. Its products serve cardiologists, internists, nephrologists, endocrinologists, podiatrists, and family practitioners, as well as healthcare insurance plans, integrated delivery networks, independent physician groups, and companies contracting with the healthcare industry, such as risk assessment groups.
Semler Scientific, Inc. Fundamentals Summary
| SMLR fundamental statistics | |
|---|---|
| Market Cap | US$167.58m |
| Earnings (TTM) | US$12.62m |
| Revenue (TTM) | US$54.43m |
13.3x
P/E Ratio3.1x
P/S RatioIs SMLR overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| SMLR income statement (TTM) | |
|---|---|
| Revenue | US$54.43m |
| Cost of Revenue | US$5.24m |
| Gross Profit | US$49.20m |
| Other Expenses | US$36.58m |
| Earnings | US$12.62m |
Last Reported Earnings
Sep 30, 2022
Next Earnings Date
n/a
| Earnings per share (EPS) | 1.84 |
| Gross Margin | 90.38% |
| Net Profit Margin | 23.18% |
| Debt/Equity Ratio | 0% |
How did SMLR perform over the long term?
See historical performance and comparison